Catalent Pharma Solutions Introduces the Secure-Vial(TM) Technology for Innovative and Cost Effective Delivery of Injectable Pharmaceuticals

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry, announces the introduction of the SECURE-VIAL™ technology, a new patent-pending delivery system for injectable drug products. Catalent is launching the SECURE-VIAL™ technology to the scientific community this week at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS).

MORE ON THIS TOPIC